{"count": 51, "results": [{"_id": "35846327", "pmid": 35846327, "pmcid": "PMC9280669", "title": "A Prospective Cohort Study of Metformin as an Adjuvant Therapy for Infertile Women With Endometrial Complex Hyperplasia/Complex Atypical Hyperplasia and Their Subsequent Assisted Reproductive Technology Outcomes", "journal": "Front Endocrinol (Lausanne)", "authors": ["Kong WY", "Liu ZA", "Zhang N", "Wu X", "Zhao XB", "Yan L"], "date": "2022-06-30T00:00:00Z", "doi": "10.3389/fendo.2022.849794", "meta_date_publication": "2022", "meta_volume": "13", "meta_issue": "", "meta_pages": "849794", "score": 50296.49, "text_hl": "A Prospective Cohort Study of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ as an Adjuvant Therapy for Infertile @SPECIES_9606 @@@Women@@@ With @<m>DISEASE_Endometrial_Hyperplasia</m> @DISEASE_MESH:D004714 @@@Endometrial Complex Hyperplasia@@@/Complex @<m>DISEASE_Endometrial_Hyperplasia</m> @DISEASE_MESH:D004714 @@@Atypical Hyperplasia@@@ and Their Subsequent Assisted Reproductive Technology Outcomes", "citations": {"NLM": "Kong WY, Liu ZA, Zhang N, Wu X, Zhao XB, Yan L. A Prospective Cohort Study of Metformin as an Adjuvant Therapy for Infertile Women With Endometrial Complex Hyperplasia/Complex Atypical Hyperplasia and Their Subsequent Assisted Reproductive Technology Outcomes Front Endocrinol (Lausanne). 2022;13():849794. PMID: 35846327", "BibTeX": "@article{35846327, title={A Prospective Cohort Study of Metformin as an Adjuvant Therapy for Infertile Women With Endometrial Complex Hyperplasia/Complex Atypical Hyperplasia and Their Subsequent Assisted Reproductive Technology Outcomes}, author={Kong WY and Liu ZA and Zhang N and Wu X and Zhao XB and Yan L}, journal={Front Endocrinol (Lausanne)}, volume={13}, pages={849794}}"}}, {"_id": "37415671", "pmid": 37415671, "pmcid": "PMC10320576", "title": "Progestin plus metformin improves outcomes in patients with endometrial hyperplasia and early endometrial cancer more than progestin alone: a meta-analysis", "journal": "Front Endocrinol (Lausanne)", "authors": ["Shao F", "Li Y", "Zhao Y"], "date": "2023-06-21T00:00:00Z", "doi": "10.3389/fendo.2023.1139858", "meta_date_publication": "2023", "meta_volume": "14", "meta_issue": "", "meta_pages": "1139858", "score": 50283.785, "text_hl": "Progestin plus @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ improves outcomes in @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Endometrial_Hyperplasia</m> @DISEASE_MESH:D004714 @@@endometrial hyperplasia@@@ and early @DISEASE_Endometrial_Neoplasms @DISEASE_MESH:D016889 @@@endometrial cancer@@@ more than progestin alone: a meta-analysis", "citations": {"NLM": "Shao F, Li Y, Zhao Y. Progestin plus metformin improves outcomes in patients with endometrial hyperplasia and early endometrial cancer more than progestin alone: a meta-analysis Front Endocrinol (Lausanne). 2023;14():1139858. PMID: 37415671", "BibTeX": "@article{37415671, title={Progestin plus metformin improves outcomes in patients with endometrial hyperplasia and early endometrial cancer more than progestin alone: a meta-analysis}, author={Shao F and Li Y and Zhao Y}, journal={Front Endocrinol (Lausanne)}, volume={14}, pages={1139858}}"}}, {"_id": "32096892", "pmid": 32096892, "title": "Is there any move to use metformin for endometrial hyperplasia in routine clinical practice?", "journal": "BJOG", "authors": ["Atiomo W"], "date": "2020-06-01T00:00:00Z", "doi": "10.1111/1471-0528.16183", "meta_date_publication": "2020 Jun", "meta_volume": "127", "meta_issue": "7", "meta_pages": "858", "score": 50281.285, "text_hl": "Is there any move to use @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ for @<m>DISEASE_Endometrial_Hyperplasia</m> @DISEASE_MESH:D004714 @@@endometrial hyperplasia@@@ in routine clinical practice?", "citations": {"NLM": "Atiomo W. Is there any move to use metformin for endometrial hyperplasia in routine clinical practice? BJOG. 2020 Jun;127(7):858. PMID: 32096892", "BibTeX": "@article{32096892, title={Is there any move to use metformin for endometrial hyperplasia in routine clinical practice?}, author={Atiomo W}, journal={BJOG}, volume={127}, number={7}, pages={858}}"}}, {"_id": "37082665", "pmid": 37082665, "pmcid": "PMC10113095", "title": "Diane-35 and metformin therapy in rats with endometrial lesions induced by dihydrotestosterone exposure", "journal": "Ann Transl Med", "authors": ["Liu Y", "Xu R", "Zhou Y", "Wang Y", "Zhang F", "Tong X", "Cui P", "Ma T", "Sun J", "Feng Y", "Li X"], "date": "2023-03-31T00:00:00Z", "doi": "10.21037/atm-21-2441", "meta_date_publication": "2023 Mar 31", "meta_volume": "11", "meta_issue": "6", "meta_pages": "247", "score": 50280.508, "text_hl": "@CHEMICAL_Cyproterone_acetate_ethinyl_estradiol_drug_combination @CHEMICAL_MESH:C032640 @@@Diane-35@@@ and @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ mediated reversal of @<m>DISEASE_Endometrial_Hyperplasia</m> @DISEASE_MESH:D004714 @@@endometrial hyperplasia@@@", "citations": {"NLM": "Liu Y, Xu R, Zhou Y, Wang Y, Zhang F, Tong X, Cui P, Ma T, Sun J, Feng Y, Li X. Diane-35 and metformin therapy in rats with endometrial lesions induced by dihydrotestosterone exposure Ann Transl Med. 2023 Mar 31;11(6):247. PMID: 37082665", "BibTeX": "@article{37082665, title={Diane-35 and metformin therapy in rats with endometrial lesions induced by dihydrotestosterone exposure}, author={Liu Y and Xu R and Zhou Y and Wang Y and Zhang F and Tong X and Cui P and Ma T and Sun J and Feng Y and Li X}, journal={Ann Transl Med}, volume={11}, number={6}, pages={247}}"}}, {"_id": "40626388", "pmid": 40626388, "title": "Fertility-sparing treatment for atypical endometrial hyperplasia and endometrial cancer.", "journal": "Cochrane Database Syst Rev", "authors": ["Fernandez-Montoli ME", "Sabadell J", "Contreras Perez NA", "Verdaguer Menéndez-Arango P", "Julia Torres C", "Lleberia J"], "date": "2025-07-08T00:00:00Z", "doi": "10.1002/14651858.CD013111.pub2", "meta_date_publication": "2025 Jul 8", "meta_volume": "7", "meta_issue": "7", "meta_pages": "CD013111", "score": 50267.55, "text_hl": "AUTHORS' CONCLUSIONS: In light of the low certainty of the evidence, it is unclear which intervention and which route of administration or dose of progestins could be of benefit compared to others for fertility-sparing management of @DISEASE_Endometrial_Neoplasms @DISEASE_MESH:D016889 @@@endometrial cancer@@@ or @<m>DISEASE_Endometrial_Hyperplasia</m> @DISEASE_MESH:D004714 @@@AEH@@@. The addition of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ to progestins may increase complete response slightly. ", "citations": {"NLM": "Fernandez-Montoli ME, Sabadell J, Contreras Perez NA, Verdaguer Menéndez-Arango P, Julia Torres C, Lleberia J. Fertility-sparing treatment for atypical endometrial hyperplasia and endometrial cancer. Cochrane Database Syst Rev. 2025 Jul 8;7(7):CD013111. PMID: 40626388", "BibTeX": "@article{40626388, title={Fertility-sparing treatment for atypical endometrial hyperplasia and endometrial cancer.}, author={Fernandez-Montoli ME and Sabadell J and Contreras Perez NA and Verdaguer Menéndez-Arango P and Julia Torres C and Lleberia J}, journal={Cochrane Database Syst Rev}, volume={7}, number={7}, pages={CD013111}}"}}, {"_id": "35875417", "pmid": 35875417, "pmcid": "PMC9297462", "title": "Hysteroscopic Curettage Followed by Megestrol Acetate Plus Metformin as a Fertility-Sparing Treatment for Women with Atypical Endometrial Hyperplasia or Well-Differentiated Endometrioid Endometrial Carcinoma", "journal": "Clin Med Insights Oncol", "authors": ["Jing CY", "Li SN", "Shan BE", "Zhang W", "Tian WJ", "Ren YL", "Wang HY"], "date": "2022-07-18T00:00:00Z", "doi": "10.1177/11795549221110522", "meta_date_publication": "2022", "meta_volume": "16", "meta_issue": "", "meta_pages": "11795549221110522", "score": 50266.426, "text_hl": "Literature review of @<m>DISEASE_Endometrial_Hyperplasia</m> @DISEASE_MESH:D004714 @@@AEH@@@ and early @DISEASE_Endometrial_Neoplasms @DISEASE_MESH:D016889 @@@EC@@@ conservatively treated by progestins combined with @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ or with hysteroscopic resection.", "citations": {"NLM": "Jing CY, Li SN, Shan BE, Zhang W, Tian WJ, Ren YL, Wang HY. Hysteroscopic Curettage Followed by Megestrol Acetate Plus Metformin as a Fertility-Sparing Treatment for Women with Atypical Endometrial Hyperplasia or Well-Differentiated Endometrioid Endometrial Carcinoma Clin Med Insights Oncol. 2022;16():11795549221110522. PMID: 35875417", "BibTeX": "@article{35875417, title={Hysteroscopic Curettage Followed by Megestrol Acetate Plus Metformin as a Fertility-Sparing Treatment for Women with Atypical Endometrial Hyperplasia or Well-Differentiated Endometrioid Endometrial Carcinoma}, author={Jing CY and Li SN and Shan BE and Zhang W and Tian WJ and Ren YL and Wang HY}, journal={Clin Med Insights Oncol}, volume={16}, pages={11795549221110522}}"}}, {"_id": "33773565", "pmid": 33773565, "pmcid": "PMC8286694", "title": "A Randomized Clinical Trial of Levonorgestrel Intrauterine System with or without Metformin for Treatment of Endometrial Hyperplasia without Atypia in Indian Women", "journal": "Asian Pac J Cancer Prev", "authors": ["Ravi RD", "Kalra J", "Srinivasan R", "Bagga R", "Jain V", "Suri V", "Sachdeva N"], "date": "2021-03-01T00:00:00Z", "doi": "10.31557/APJCP.2021.22.3.983", "meta_date_publication": "2021 Mar 1", "meta_volume": "22", "meta_issue": "3", "meta_pages": "983-989", "score": 50266.176, "text_hl": "In recent years following the case report of use of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ to treat @<m>DISEASE_Endometrial_Hyperplasia</m> @DISEASE_MESH:D004714 @@@EH@@@ (Session et al., 2003), various trials have come up with @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ as a management option for @<m>DISEASE_Endometrial_Hyperplasia</m> @DISEASE_MESH:D004714 @@@EH@@@. ", "citations": {"NLM": "Ravi RD, Kalra J, Srinivasan R, Bagga R, Jain V, Suri V, Sachdeva N. A Randomized Clinical Trial of Levonorgestrel Intrauterine System with or without Metformin for Treatment of Endometrial Hyperplasia without Atypia in Indian Women Asian Pac J Cancer Prev. 2021 Mar 1;22(3):983-989. PMID: 33773565", "BibTeX": "@article{33773565, title={A Randomized Clinical Trial of Levonorgestrel Intrauterine System with or without Metformin for Treatment of Endometrial Hyperplasia without Atypia in Indian Women}, author={Ravi RD and Kalra J and Srinivasan R and Bagga R and Jain V and Suri V and Sachdeva N}, journal={Asian Pac J Cancer Prev}, volume={22}, number={3}, pages={983-989}}"}}, {"_id": "32376736", "pmid": 32376736, "title": "Route-specific association of progestin therapy and concurrent metformin use in obese women with complex atypical hyperplasia.", "journal": "Int J Gynecol Cancer", "authors": ["Matsuo K", "Mandelbaum RS", "Ciccone M", "Khoshchehreh M", "Pursuwani H", "Morocco EB", "Matsuzaki S", "Dancz CE", "Ozel B", "Paulson RJ", "Roman L"], "date": "2020-09-01T00:00:00Z", "doi": "10.1136/ijgc-2020-001362", "meta_date_publication": "2020 Sep", "meta_volume": "30", "meta_issue": "9", "meta_pages": "1331-1339", "score": 50265.855, "text_hl": "Route-specific association of progestin therapy and concurrent @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ use in @DISEASE_Obesity @DISEASE_MESH:D009765 @@@obese@@@ @SPECIES_9606 @@@women@@@ with @<m>DISEASE_Endometrial_Hyperplasia</m> @DISEASE_MESH:D004714 @@@complex atypical hyperplasia@@@.", "citations": {"NLM": "Matsuo K, Mandelbaum RS, Ciccone M, Khoshchehreh M, Pursuwani H, Morocco EB, Matsuzaki S, Dancz CE, Ozel B, Paulson RJ, Roman L. Route-specific association of progestin therapy and concurrent metformin use in obese women with complex atypical hyperplasia. Int J Gynecol Cancer. 2020 Sep;30(9):1331-1339. PMID: 32376736", "BibTeX": "@article{32376736, title={Route-specific association of progestin therapy and concurrent metformin use in obese women with complex atypical hyperplasia.}, author={Matsuo K and Mandelbaum RS and Ciccone M and Khoshchehreh M and Pursuwani H and Morocco EB and Matsuzaki S and Dancz CE and Ozel B and Paulson RJ and Roman L}, journal={Int J Gynecol Cancer}, volume={30}, number={9}, pages={1331-1339}}"}}, {"_id": "36333773", "pmid": 36333773, "pmcid": "PMC9636609", "title": "Levonorgestrel-releasing intrauterine device plus metformin, or megestrol acetate plus metformin for fertility-sparing treatment of atypical endometrial hyperplasia and early endometrial carcinoma: a prospective, randomized, blind-endpoint design trial protocol", "journal": "Reprod Health", "authors": ["Zhao X", "Niu J", "Shi C", "Liu Z"], "date": "2022-11-04T00:00:00Z", "doi": "10.1186/s12978-022-01513-8", "meta_date_publication": "2022 Nov 4", "meta_volume": "19", "meta_issue": "1", "meta_pages": "206", "score": 50265.777, "text_hl": "@CHEMICAL_Levonorgestrel @CHEMICAL_MESH:D016912 @@@Levonorgestrel@@@-releasing intrauterine device plus @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@, or @CHEMICAL_Megestrol_Acetate @CHEMICAL_MESH:D019290 @@@megestrol acetate@@@ plus @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ for fertility-sparing treatment of atypical @<m>DISEASE_Endometrial_Hyperplasia</m> @DISEASE_MESH:D004714 @@@endometrial hyperplasia@@@ and early @DISEASE_Endometrial_Neoplasms @DISEASE_MESH:D016889 @@@endometrial carcinoma@@@: a prospective, randomized, blind-endpoint design trial protocol", "citations": {"NLM": "Zhao X, Niu J, Shi C, Liu Z. Levonorgestrel-releasing intrauterine device plus metformin, or megestrol acetate plus metformin for fertility-sparing treatment of atypical endometrial hyperplasia and early endometrial carcinoma: a prospective, randomized, blind-endpoint design trial protocol Reprod Health. 2022 Nov 4;19(1):206. PMID: 36333773", "BibTeX": "@article{36333773, title={Levonorgestrel-releasing intrauterine device plus metformin, or megestrol acetate plus metformin for fertility-sparing treatment of atypical endometrial hyperplasia and early endometrial carcinoma: a prospective, randomized, blind-endpoint design trial protocol}, author={Zhao X and Niu J and Shi C and Liu Z}, journal={Reprod Health}, volume={19}, number={1}, pages={206}}"}}, {"_id": "32652300", "pmid": 32652300, "title": "The impact of adjunctive metformin to progesterone for the treatment of non-atypical endometrial hyperplasia in a randomized fashion, a placebo-controlled, double blind clinical trial.", "journal": "J Gynecol Obstet Hum Reprod", "authors": ["Tehranian A", "Ghahghaei-Nezamabadi A", "Arab M", "Khalagi K", "Aghajani R", "Sadeghi S"], "date": "2021-06-01T00:00:00Z", "doi": "10.1016/j.jogoh.2020.101863", "meta_date_publication": "2021 Jun", "meta_volume": "50", "meta_issue": "6", "meta_pages": "101863", "score": 50263.59, "text_hl": "Most recently, @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ has been suggested as an adjuvant medication for treating of @<m>DISEASE_Endometrial_Hyperplasia</m> @DISEASE_MESH:D004714 @@@EH@@@ with better outcome. ", "citations": {"NLM": "Tehranian A, Ghahghaei-Nezamabadi A, Arab M, Khalagi K, Aghajani R, Sadeghi S. The impact of adjunctive metformin to progesterone for the treatment of non-atypical endometrial hyperplasia in a randomized fashion, a placebo-controlled, double blind clinical trial. J Gynecol Obstet Hum Reprod. 2021 Jun;50(6):101863. PMID: 32652300", "BibTeX": "@article{32652300, title={The impact of adjunctive metformin to progesterone for the treatment of non-atypical endometrial hyperplasia in a randomized fashion, a placebo-controlled, double blind clinical trial.}, author={Tehranian A and Ghahghaei-Nezamabadi A and Arab M and Khalagi K and Aghajani R and Sadeghi S}, journal={J Gynecol Obstet Hum Reprod}, volume={50}, number={6}, pages={101863}}"}}]}